The Promise of Genome Edited Pigs for Organ Regeneration
Hiroshi Nagashima, Director and Professor, Meiji University International Institute for Bio-Resource Research
Generation of functional organs from pluripotent stem cells (PSCs) is
one of the ultimate goals of regenerative medicine. We have advocated a
concept of generating human organs from PSCs by organogenesis in
xenogeneic animals. This concept consists of two fundamental
technologies, i.e., induction of an empty developmental niche in the
organogenesis of pig fetus and its compensation by exogenous iPSCs
through blastocyst complementation. We have so far demonstrated the
production of genetically modified pigs with an organogenesis-disabled
phenotype in various organs, including pancreas, kidney, liver, and
blood vessels. We also demonstrated the applicability of the blastocyst
complementation technique in an allogenic setting for compensating the
dysorganogenetic phenotypes of the pigs. Current challenges and future
prospects of generating human organs by interspecific blastocyst
complementation will be discussed.
|
|